Your browser is no longer supported. Please, upgrade your browser.
MYOS MYOS RENS Technology Inc. daily Stock Chart
MYOS RENS Technology Inc.
Index- P/E- EPS (ttm)-0.45 Insider Own34.50% Shs Outstand9.72M Perf Week-0.94%
Market Cap11.40M Forward P/E- EPS next Y-0.39 Insider Trans41.19% Shs Float5.51M Perf Month-0.98%
Income-4.10M PEG- EPS next Q- Inst Own5.50% Short Float0.92% Perf Quarter-21.09%
Sales1.20M P/S9.50 EPS this Y-7.10% Inst Trans-1.43% Short Ratio0.13 Perf Half Y-31.98%
Book/sh0.27 P/B3.74 EPS next Y23.50% ROA-112.70% Target Price- Perf Year-16.53%
Cash/sh0.06 P/C16.29 EPS next 5Y- ROE-176.30% 52W Range0.74 - 1.80 Perf YTD-16.53%
Dividend- P/FCF- EPS past 5Y20.90% ROI-175.80% 52W High-43.89% Beta1.06
Dividend %- Quick Ratio1.00 Sales past 5Y-20.90% Gross Margin57.90% 52W Low36.27% ATR0.16
Employees15 Current Ratio2.90 Sales Q/Q200.00% Oper. Margin- RSI (14)48.87 Volatility25.54% 13.86%
OptionableNo Debt/Eq0.23 EPS Q/Q29.90% Profit Margin- Rel Volume2.65 Prev Close1.03
ShortableYes LT Debt/Eq0.00 EarningsMay 08 BMO Payout- Avg Volume383.50K Price1.01
Recom- SMA20-3.08% SMA502.10% SMA200-22.38% Volume1,015,234 Change-1.94%
May-21-20 08:00AM  MYOS RENS Partners with to Promote MYOS Longevity's Clinically-Backed Nutrition Products PR Newswire +9.90%
May-14-20 08:00AM  MYOS RENS Enters into Agreement with Victor Medical to Distribute MYOS Canine Muscle Formula® Across Western United States PR Newswire +7.21%
May-13-20 03:19AM  Edited Transcript of MYOS earnings conference call or presentation 8-May-20 3:30pm GMT Thomson Reuters StreetEvents -5.83%
May-08-20 08:00AM  MYOS RENS Technology Reports First Quarter 2020 Financial Results Including a 95% Increase in Net Revenues PR Newswire
May-04-20 08:00AM  MYOS RENS Technology Announces the Date for First Quarter 2020 Conference Call and Webcast PR Newswire
Apr-29-20 07:46AM  Benzinga Pro's Top 5 Stocks To Watch For Wed., Apr. 29, 2020: FB, IBM, SHOP, MNST, MYOS Benzinga
Apr-28-20 08:00AM  MYOS RENS Announces that Multiple Top-Tier Pet Insurance Companies Now Cover its Canine Nutrition Products PR Newswire +6.23%
Apr-15-20 08:00AM  MYOS RENS Announces Publication of Landmark Clinical Study on Recovery in Dogs Following TPLO Surgery PR Newswire +13.79%
Mar-30-20 02:26AM  Edited Transcript of MYOS earnings conference call or presentation 25-Mar-20 3:00pm GMT Thomson Reuters StreetEvents
Mar-25-20 09:00AM  MYOS RENS Technology, Inc. to Host Earnings Call ACCESSWIRE +7.39%
06:00AM  MYOS RENS Technology Reports a 187% Increase in Net Revenues for the Year Ended December 31, 2019 PR Newswire
Mar-19-20 08:00AM  MYOS RENS Technology Announces Date of Fourth Quarter 2019 Financial Results, Conference Call and Webcast PR Newswire
Mar-12-20 08:00AM  MYOS RENS Partners with UNFI, a Nationwide Distributor of Natural, Organic and Specialty Food PR Newswire -7.72%
Mar-10-20 08:00AM  MYOS RENS Announces Distribution and Co-Marketing Agreement with KVP International, a Leading Distributor of Veterinary Rehabilitation Products PR Newswire +26.12%
Feb-06-20 10:08AM  Does The MYOS RENS Technology Inc. (NASDAQ:MYOS) Share Price Tend To Follow The Market? Simply Wall St.
09:00AM  MYOS RENS Hires College Football Icon and Inspirational Speaker Eric LeGrand as a Special Advisor for its YOLKED® Sports Nutrition Brand PR Newswire
Jan-30-20 07:00AM  MYOS Announces Distribution Partnership for Their Blockbuster Canine Muscle Formula with Chewy, a Leading Online Retailer of Pet Food and Pet-Related Products PR Newswire
Jan-15-20 07:00AM  MYOS RENS Technology to Provide Exciting Updates on New Product and Clinical Research at the Veterinary Meeting & Expo in Orlando, January 19-22, 2020 PR Newswire -8.76%
Jan-09-20 07:00AM  MYOS CEO Joseph Mannello Issues Letter to Shareholders PR Newswire
Dec-23-19 10:58AM  Imagine Owning MYOS RENS Technology (NASDAQ:MYOS) And Trying To Stomach The 83% Share Price Drop Simply Wall St.
Dec-17-19 07:00AM  Albert Ahn, DVM, Expert in Animal Medicine, Joins MYOS as Strategic Adviser to Build Veterinary Business Focused on Muscle Health ACCESSWIRE
Dec-10-19 07:01AM  MYOS to Introduce its Longevity Business with its Physician Muscle Health Formula at the World Congress on Anti-Aging Medicine in Las Vegas December 13-15, 2019 PR Newswire
Dec-02-19 09:27AM  Edited Transcript of MYOS earnings conference call or presentation 8-Nov-19 3:00pm GMT Thomson Reuters StreetEvents
Nov-26-19 06:55AM  MYOS: Q3 2019 Update: Positive Clinical Data, Word-of-Mouth Driving Consumer & Professional Demand Zacks Small Cap Research -9.26%
Nov-20-19 07:27AM  MYOS RENS' Fortetropin® Clinical Trial Results to be Presented by William J. Evans, Ph.D., at the International Conference on Frailty and Sarcopenia Research PR Newswire
Nov-14-19 07:00AM  MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders Summarizing Milestone Achievements and Ongoing Growth Strategy PR Newswire +6.18%
Nov-07-19 05:14PM  MYOS RENS Technology Reports Third Quarter 2019 Financial Results Including Year-Over-Year Revenue Growth of 430% PR Newswire
Nov-05-19 07:00AM  MYOS RENS Technology Launches Exclusive 'Veterinarian Strength' Myos Canine Muscle Formula PR Newswire
Oct-31-19 06:00AM  MYOS RENS Technology Announces the Date for the Release of Third Quarter 2019 Financial Results, Conference Call and Webcast PR Newswire
Oct-30-19 07:00AM  MYOS RENS Technology Partners with the Texas Golf Association to Introduce Yolked® to Strategic Demographic PR Newswire
Oct-23-19 10:59AM  Is MYOS RENS Technology (NASDAQ:MYOS) Using Debt Sensibly? Simply Wall St. -5.71%
Oct-22-19 07:00AM  MYOS RENS Technology to Exhibit MYOS Canine Muscle Formula® at the New York Vet Show in New York City, November 7- 8, 2019 PR Newswire
Sep-17-19 10:58AM  Read This Before Selling MYOS RENS Technology Inc. (NASDAQ:MYOS) Shares Simply Wall St.
Sep-10-19 08:00AM  MYOS RENS Technology Enters into Research Agreement with McMaster University to Study Impact of Fortetropin® on Muscle Disuse Atrophy in Young Men PR Newswire
Aug-29-19 01:30PM  Edited Transcript of MYOS earnings conference call or presentation 7-Aug-19 3:00pm GMT Thomson Reuters StreetEvents
Aug-22-19 08:00AM  MYOS RENS Technology Kicks Off College Football Season with the Launch of the Yolked® Rose Bowl Stadium Sweepstakes PR Newswire
Aug-12-19 03:14PM  One Thing To Remember About The MYOS RENS Technology Inc. (NASDAQ:MYOS) Share Price Simply Wall St. -5.33%
Aug-08-19 09:00AM  MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders Outlining First Half 2019 Accomplishments and Opportunities for Future Growth PR Newswire
Aug-06-19 08:09PM  MYOS RENS Technology Reports 75% Net Revenue Growth in Second Quarter, 109% Net Revenue Growth in First Half of 2019 PR Newswire
Jul-31-19 01:08PM  MYOS RENS Technology Announces the Date for the Release of Second Quarter and First Half 2019 Results, Conference Call and Webcast PR Newswire
Jul-08-19 02:37PM  MYOS RENS Technology Congratulates the United States Women's National Soccer Team and Team Yolked® Member Carli Lloyd on Winning the 2019 FIFA Women's World Cup PR Newswire
Jun-27-19 06:46AM  Introducing MYOS RENS Technology (NASDAQ:MYOS), The Stock That Tanked 88% Simply Wall St. -10.59%
Jun-20-19 03:15PM  MYOS: UC Berkeley Study Results Should Help Open New, Large Market for Fortetropin Zacks Small Cap Research
Jun-18-19 06:09PM  MYOS RENS' Fortetropin® Shown to Increase the Rate of Muscle Protein Synthesis in Older Adults in Clinical Study Carried out at University of California, Berkeley PR Newswire
05:46PM  Edited Transcript of MYOS earnings conference call or presentation 9-May-19 3:00pm GMT Thomson Reuters StreetEvents
May-29-19 07:05AM  MYOS RENS Technology Announces Endorsement Partnership for Yolked® with Carli Lloyd, Two-Time Olympic Gold Medalist, FIFA Women's World Cup Champion, and Captain of the United States Women's National Soccer Team PR Newswire
May-23-19 10:10AM  MYOS: Q1 2019: MYOS Canine Sales Jump, Initial Reviews are Highly Encouraging. New QoL Dog Study Planned Zacks Small Cap Research
May-21-19 07:30AM  MYOS RENS Technology to Present at the 9th Annual LD Micro Invitational in Los Angeles, CA PR Newswire
May-08-19 06:00PM  MYOS RENS Technology Reports 161% Increase in Revenues, 238% Increase in Gross Profit in First Quarter 2019 PR Newswire
May-01-19 07:30AM  MYOS RENS Technology Announces the Date for the Release of First Quarter 2019 Results, Conference Call and Webcast PR Newswire
Apr-04-19 05:45AM  MYOS RENS Technology Signs Distribution Agreement with National Sales Associates, LLC PR Newswire +6.08%
Apr-02-19 10:00AM  MYOS: Yolked, MYOS Canine Formula Sales Accelerating. Going Into 2019 w/ New Clinical Evidence and Marketing Initiatives Zacks Small Cap Research
Mar-28-19 06:00AM  MYOS RENS Technology Reports Fourth Quarter and Fiscal 2018 Results PR Newswire +14.89%
Mar-27-19 09:15PM  Myos Rens Technology Inc (MYOS) CEO Joseph Mannello Bought $250,000 of Shares
Mar-26-19 07:30AM  MYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Fiscal Year 2018 Results, Conference Call and Webcast PR Newswire
Feb-27-19 07:16AM  MYOS RENS Technology Announces Initiation of a Study at Kansas State University to Evaluate the Impact of Fortetropin® on Quality of Life and Activity in Geriatric Dogs PR Newswire
Feb-21-19 07:16AM  Should You Be Concerned About MYOS RENS Technology Inc.s (NASDAQ:MYOS) Historical Volatility? Simply Wall St.
Feb-19-19 08:25AM  Report: Exploring Fundamental Drivers Behind Crocs, Portola Pharmaceuticals, ANSYS, Alpha and Omega Semiconductor, PetMed Express, and MYOS RENS Technology New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-07-19 07:30AM  MYOS RENS Technology Announces First Endorsement Deal for Yolked® with NBA Superstar Aaron Gordon PR Newswire
Jan-24-19 01:25PM  MYOS: Positive Results of Canine Muscle Recovery Study Should Benefit Uptake, Inform Human Development Programs Zacks Small Cap Research
Jan-23-19 08:00AM  MYOS CEO Joseph Mannello Issues Letter to Shareholders Following Presentation at North American Veterinary Community (NAVC) Conference/VMX PR Newswire
Jan-15-19 07:00AM  MYOS RENS Technology Announces Study Results Demonstrating Fortetropin®, the Active Ingredient in Myos Canine Muscle Formula, Prevents Muscle Loss in Canines After Surgery and Enhances Recovery PR Newswire +9.74%
Jan-08-19 06:05AM  MYOS RENS Technology Announces Upcoming Presentation of Results from a Kansas State University Study Evaluating the Impact of Fortetropin® on Canine Muscle Loss after Surgery, at a Major Veterinary Conference, January 20, 2019 PR Newswire +5.67%
Jan-03-19 06:05AM  MYOS RENS Technology Receives a New Patent from the United States Patent and Trademark Office PR Newswire
Dec-25-18 11:42AM  Have Insiders Been Buying MYOS RENS Technology Inc. (NASDAQ:MYOS) Shares? Simply Wall St.
Dec-14-18 06:05AM  MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders PR Newswire
Dec-13-18 04:05PM  MYOS RENS Technology Announces Results of Its 2018 Annual Meeting of Stockholders PR Newswire
Dec-12-18 06:50AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Corcept Therapeutics ACCESSWIRE -15.88%
Dec-11-18 12:11PM  Why MYOS Stock Is Skyrocketing Today InvestorPlace +55.96%
10:29AM  Myos Shares Find Nourishment From Vitamin Shoppe Distribution Deal Benzinga
06:05AM  MYOS RENS Technology Launches 'Yolked®', Its Sports Nutrition Product, With The Vitamin Shoppe® Nationwide PR Newswire
Dec-06-18 06:10AM  MYOS RENS Technology Announces Approval of $1.2 Million in NJEDA NOL Program Tax Credits PR Newswire +5.36%
Dec-04-18 03:30PM  MYOS: MYOS Canine Initial Sales and Add l Distribution. Yolked Feedback Positive. Medical Nutrition Could Be Compelling Growth Opportunity Zacks Small Cap Research
Nov-14-18 04:15PM  MYOS RENS Technology Reports Financial Results for the Third Quarter of 2018 and Business Updates PR Newswire -7.09%
Nov-08-18 06:10AM  MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula To 6,000+ Veterinary Hospitals PR Newswire
Nov-06-18 05:26PM  MYOS RENS Technology Announces The Date For The Release Of Third Quarter 2018 Results, Conference Call And Webcast PR Newswire +5.79%
Oct-16-18 08:20AM  Investor Expectations to Drive Momentum within Pacific Ethanol, CorVel, Surmodics, Alpha and Omega Semiconductor, MYOS RENS Technology, and Golden Entertainment Discovering Underlying Factors of Influence GlobeNewswire
Oct-02-18 06:10AM  Centers For Medicare and Medicaid Services Approves Reimbursement For Unique Fortetropin®-Based Enteral Nutrition Formula PR Newswire
Sep-26-18 07:00AM  MYOS RENS Technology To Exhibit MYOS Canine Muscle Formula At The Atlantic Coast Veterinary Conference, October 8-11, 2018 PR Newswire
Sep-11-18 11:20AM  Should You Have MYOS RENS Technology Incs (NASDAQ:MYOS) In Your Portfolio? Simply Wall St.
Aug-17-18 02:00PM  MYOS: Yolked Well-Received, MYOS Canine Formula Launched Zacks Small Cap Research
08:20AM  Consolidated Research: 2018 Summary Expectations for PDF Solutions, MYOS RENS Technology, Aldeyra Therapeutics, The Ensign Group, Everi, and Ardelyx Fundamental Analysis, Key Performance Indications GlobeNewswire
Aug-08-18 05:39PM  MYOS RENS Technology Reports 49% Increase In Net Revenues In Second Quarter Of 2018 PR Newswire
Aug-02-18 06:15AM  MYOS RENS Technology Announces The Date For The Release Of Second Quarter And First Half 2018 Results, Conference Call And Webcast PR Newswire -10.14%
Jul-12-18 08:00AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Canopy Growth ACCESSWIRE -25.38%
Jun-06-18 06:10AM  MYOS RENS Technology Launches Advanced Veterinary Supplement Product For Dogs, Powered By Fortetropin® PR Newswire
May-31-18 07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within Insulet, Everi, Ciner Resources LP, Aluminum Corporation of China, Okta, and MYOS RENS Technology New Research Emphasizes Economic Growth GlobeNewswire -5.01%
May-24-18 10:11AM  Should You Buy MYOS RENS Technology Inc (NASDAQ:MYOS) Now? Simply Wall St.
May-16-18 09:45AM  MYOS: Several Development-Related Milestones Upcoming Zacks Small Cap Research
May-09-18 05:36PM  MYOS RENS Technology Reports First Quarter Financial Results PR Newswire +13.14%
May-03-18 08:02PM  /C O R R E C T I O N -- MYOS RENS Technology Inc./ PR Newswire -6.47%
Apr-20-18 07:20AM  Free Research Report as Lipocine Announced FY17 Financial Results ACCESSWIRE
Apr-12-18 10:00AM  MYOS: A New Product For Sports Nutrition Zacks Small Cap Research
Apr-10-18 09:11AM  Was MYOS RENS Technology Incs (NASDAQ:MYOS) Earnings Growth Better Than The Industrys? Simply Wall St.
06:10AM  MYOS RENS Technology Introduces New Sports Nutrition Product Line, Yolked, and Earns Prestigious "Certified For Sport®" Certification From NSF International PR Newswire
Apr-06-18 07:55AM  Detailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands, MYOS RENS Technology, Avadel Pharmaceuticals, Energizer, and BJ's Restaurants What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-03-18 03:15PM  MYOS: Initiation Report Zacks Small Cap Research +8.06%
02:54PM  MYOS RENS Technology to Present at the MicroCap Conference April 10 in New York City at the Essex House PR Newswire
Mar-28-18 01:53PM  MYOS RENS Technology CEO Joseph Mannello Provides Comments On Operational And Financial Results For Fiscal Year 2017 PR Newswire
08:00AM  MYOS RENS Technology Inc. to Host Earnings Call ACCESSWIRE
MYOS RENS Technology Inc. focuses on the discovery, development, and commercialization of nutritional ingredients, functional foods, and other technologies that enhance muscle health and performance. The company primarily focuses on developing Fortetropin for the therapeutic markets, including the treatment of sarcopenia, cachexia, anorexia, obesity, and muscular disorders. Its products include Qurr line of products to support muscle well-being and fitness; Yolked line of products for collegiate and professional athletes; and Myos Canine Muscle Formula line of products for pets. The company sells its products through direct-to-consumer e-commerce platform. It has a research agreement with the University of California to study the effects Of Fortetropin on skeletal muscle protein synthetic rate in older men and women; Rutgers University for the discovery of compounds and products that improve muscle health and performance; Weill Cornell Medical College to study the efficacy of Fortetropin in preventing weight and muscle loss associated with cancer; and McMaster University to study impact of Fortetropin on muscle disuse atrophy in young men. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MATLIN DAVID J10% OwnerMar 06Buy1.21206,611249,9991,267,477Mar 10 04:19 PM
Mannello JosephChief Executive OfficerMar 05Buy1.21681,818825,0001,371,028Mar 09 05:05 PM
Dewey Christopher CDirectorMar 05Buy1.2182,645100,000322,371Mar 09 05:03 PM
PECHOCK CHRISTOPHERDirectorMar 05Buy1.2182,645100,000339,802Mar 09 05:04 PM
Ponte Andrew JoelDirectorMar 05Buy1.2182,645100,00094,193Mar 09 05:03 PM